These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 2859871)

  • 1. Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
    Riddell JG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1985 Apr; 19(4):405-10. PubMed ID: 2859871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure lowering action and alpha-adrenolytic effect of adimolol in rats.
    Palluk R; Hoefke W
    Arch Int Pharmacodyn Ther; 1989; 301():215-27. PubMed ID: 2576194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adimolol, a long acting beta-adrenoceptor blocker in man.
    Elliott HL; Jones CR; Deighton NM; Meredith PA; Reid JL
    Br J Clin Pharmacol; 1987 May; 23(5):511-21. PubMed ID: 2885022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodynamics of carvedilol in normal subjects compared with propranolol, pindolol, and labetalol.
    Tomlinson B; Cronin CJ; Graham BR; Prichard BN
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S69-75. PubMed ID: 2454372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
    Tomlinson B; Bompart F; Graham BR; Liu JB; Prichard BN
    Drugs; 1988; 36 Suppl 6():37-47. PubMed ID: 2908303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological effects of labetalol in man.
    Richards DA
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):721-3. PubMed ID: 10949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of labetalol and propranolol in healthy men at rest and during exercise.
    Richards DA; Woodings EP; Maconochie JG
    Br J Clin Pharmacol; 1977 Feb; 4(1):15-21. PubMed ID: 843418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta blockade by oral propranolol and labetalol.
    Cubeddu LX; Carr ME; Fuenmayor NJ
    Clin Pharmacol Ther; 1985 Mar; 37(3):277-83. PubMed ID: 2857602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological basis for antihypertensive effects of intravenous labetalol.
    Richards DA; Prichard BN; Boakes AJ; Tuckman J; Knight EJ
    Br Heart J; 1977 Jan; 39(1):99-106. PubMed ID: 12778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dose dependency of the alpha- and beta-adrenoceptor antagonist activity of carvedilol in man.
    Tham TC; Guy S; McDermott BJ; Shanks RG; Riddell JG
    Br J Clin Pharmacol; 1995 Jul; 40(1):19-23. PubMed ID: 8527263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
    Lammintausta R; Koulu M; Allonen H
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):240-43. PubMed ID: 38214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers.
    Riva E; Mennini T; Latini R
    Br J Pharmacol; 1991 Dec; 104(4):823-8. PubMed ID: 1687367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties.
    Elliott HL; McLean K; Meredith PA; Sumner DJ; Reid JL
    Br J Clin Pharmacol; 1984 May; 17(5):565-72. PubMed ID: 6145440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of labetalol and propranolol on blood pressure at rest and during isometric and dynamic exercise.
    Nyberg G; Vedin A; Wilhelmsson C
    Eur J Clin Pharmacol; 1979 Nov; 16(5):299-303. PubMed ID: 520397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autonomic and antihypertensive activity of oral amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent in conscious rats.
    Honda K; Takenaka T; Shiono K; Miyata-Osawa A; Nakagawa C
    Jpn J Pharmacol; 1985 May; 38(1):31-41. PubMed ID: 2862302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.
    Richards DA; Tuckman J; Prichard BN
    Br J Clin Pharmacol; 1976 Oct; 3(5):849-55. PubMed ID: 9968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dose dependency of the alpha-adrenoceptor antagonist and beta-adrenoceptor partial agonist activity of dilevalol and labetalol in man.
    Tham TC; McKaigue JP; Guy S; Shanks RG; Riddell JG
    Br J Clin Pharmacol; 1993 Sep; 36(3):251-6. PubMed ID: 9114912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of arotinolol, labetalol and propranolol on regional myocardial dysfunction induced by flow-limiting coronary stenosis in anesthetized dogs.
    Noguchi K; Kato T; Kinjo N; Moromizato H; Sakanashi M
    Jpn J Pharmacol; 1990 Jul; 53(3):381-91. PubMed ID: 1697348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-adrenoceptor blockade by labetalol during long-term dosing.
    Semplicini A; Pessina AC; Rossi GP; Hlede M; Morandin F
    Clin Pharmacol Ther; 1983 Mar; 33(3):278-82. PubMed ID: 6130864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.